| Product Code: ETC9561227 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Opioid Induced Constipation Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 Sweden Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid-induced constipation in Sweden |
4.2.2 Growing awareness among healthcare professionals about the need for effective treatment options |
4.2.3 Technological advancements in drug formulation and delivery for better efficacy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for opioid-induced constipation drugs |
4.3.2 Limited availability of approved drugs in the market |
4.3.3 Concerns about side effects and misuse of opioid-induced constipation drugs |
5 Sweden Opioid Induced Constipation Drugs Market Trends |
6 Sweden Opioid Induced Constipation Drugs Market, By Types |
6.1 Sweden Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 Sweden Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Sweden Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Sweden Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 Sweden Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 Sweden Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 Sweden Opioid Induced Constipation Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed opioid-induced constipation drugs |
8.2 Number of healthcare facilities offering specialized treatment for opioid-induced constipation |
8.3 Rate of adoption of new drug formulations or treatment guidelines |
9 Sweden Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 Sweden Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 Sweden Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sweden Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Sweden Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Sweden Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 Sweden Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here